FindTrial
Sign In

Clinical effectiveness of the method of kidney-invigorating and spleen-strengthening in treating oligospermia and asthenospermia: a randomized controlled trial

Clinical effectiveness of the method of kidney-invigorating and spleen-strengthening in Treating oligospermia and asthenospermia: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031371
Enrollment
Unknown
Registered
2020-03-29
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oligospermia and asthenospermia

Interventions

Control group:Yishenjianpi traditional Chinese medicine combined with Dongweili oral liquid
Treatment group:Yishen Jianpi Chinese Herbal Medicine

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
23 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 23 -50 years. 2. Meet the diagnostic criteria for male infertility and the criteria for determining asthenozoospermia. 3. Meet the standard of syndrome differentiation of kidney essence deficiency in traditional Chinese medicine. 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: People with allergies and allergies to experimental drugs.

Design outcomes

Primary

MeasureTime frame
Semen routine;Traditional Chinese medicine syndrome score;—

Countries

China

Contacts

Public ContactJianwei Shang

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

sjw3124@163.com+86 18134048843

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026